STUDIO

Alligator Investor

BioStock Investor Pitch: Alligator Bioscience

How is Alligator Bioscience preparing to move forward after FDA approval? CEO Søren Bregenholt presents the company, which develops tumour-directed antibodies, and gives us...

RECOMMENDED READING

Spago_radiopharma_commercial_opportunity

Spago Nanomedical’s CEO: “huge commercial opportunities are unfolding”

Last week we saw the USD 2 billion buyout of Fusion Pharmaceuticals by AstraZeneca...
Alligator to maximise immuno-oncology innovation

Alligator to maximise immuno-oncology innovation

With ongoing partnering discussion for the phase III trial with mitazalimab, Alligator Bioscience can...

EVENT